Milk protein concentrate-based microencapsulation wall material and microcapsules

US11964249B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11964249-B2
Application numberUS-202017123415-A
CountryUS
Kind codeB2
Filing dateDec 16, 2020
Priority dateJun 27, 2018
Publication dateApr 23, 2024
Grant dateApr 23, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure discloses a milk protein concentrate-based microencapsulation wall material and microcapsules, and belongs to the technical field of microcapsule preparation. In the disclosure, liquid or solid microcapsules are prepared by performing cation exchange treatment on milk protein concentrates, and then using the treated milk protein concentrates as a wall material. The prepared microcapsules have good physical and chemical stability during storage, and are suitable for protecting active functional factors and to be applied in the fields of food, medicine, health care products, cosmetics, daily chemicals and the like.

First claim

Opening claim text (preview).

What is claimed is: 1. A microcapsule, comprising: a wall material, and a core material, wherein the wall material comprises a pretreated milk protein concentrate (MPC), wherein the core material comprises one or more of vitamins, unsaturated fatty acids, probiotics, vaccines, and essential oils; and wherein the pretreated MPC is prepared by subjecting the MPC to any one or more of the following: a) stirring ion exchange resin with the MPC, b) adding an acid to the MPC, wherein the acid is selected from one or more of hydrochloric acid, sulfuric acid, acetic acid, and glucolactone, and then subjecting the MPC to ultrafiltration, and c) adding a calcium ion chelator to the MPC, wherein the chelator is selected from one or more of ethylene diamine tetraacetic acid (EDTA), citric acid, malic acid, and tartrate. 2. The microcapsule of claim 1 , wherein a mass ratio of the ion exchange resin to the MPC in dry weight is 1:30 to 3:1. 3. The microcapsule of claim 1 , wherein stirring the ion exchange resin with the MPC is performed and comprises: adding 0.1 g to 30 g of the ion exchange resin to 100 g of the MPC to obtain a mixed solution, and stirring the mixed solution for a period of time for treatment. 4. The microcapsule of claim 1 , wherein the pretreatment is performed until a decalcification rate is 45% or above. 5. The microcapsule of claim 1 , wherein when the ion exchange resin is used, a mass ratio of the ion exchange resin to the MPC in dry weight is 1:30 to 3:1; and wherein the pretreatment is performed until a decalcification rate is 45% or above. 6. The microcapsule of claim 1 , wherein preparing the microcapsule comprises: homogenizing the pretreated MPC at 10 Mpa to 50 MPa, adding the core material according to a mass ratio of the core material to the wall material of 1:50 to 1:1 (w/w); stirring, dispersing by a high-speed shearing disperser; and homogenizing the mixture 2 to 6 times at a pressure of 10 MPa to 50 MPa to obtain a uniform emulsion. 7. The microcapsule of claim 6 , wherein wherein preparing the microcapsule further comprises: spray-drying or freeze-drying the uniform emulsion to prepare microcapsule powder; wherein the spray-drying is performed at an inlet temperature of 120° C. to 160° C. and an outlet temperature controlled at 60° C. to 90° C.; and wherein the freeze-drying is performed by freezing the emulsion into a solid state under liquid nitrogen or at −80° C. 8. The microcapsule of claim 1 , wherein an encapsulation rate of the core material is from about 84.4% to about 96.3%. 9. The microcapsule of claim 1 , wherein the core material is an unsaturated fatty acid. 10. The microcapsule of claim 6 , wherein the microcapsule emulsion forms a continuous viscoelastic interface.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11964249B2 cover?
The disclosure discloses a milk protein concentrate-based microencapsulation wall material and microcapsules, and belongs to the technical field of microcapsule preparation. In the disclosure, liquid or solid microcapsules are prepared by performing cation exchange treatment on milk protein concentrates, and then using the treated milk protein concentrates as a wall material. The prepared micro…
Who is the assignee on this patent?
Univ Jiangnan
What technology area does this patent fall under?
Primary CPC classification B01J13/04. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).